1. Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results. Issue 3 (17th April 2013) Authors: Zantek, N. D.; Hsu, P.; Refaai, M. A.; Ledford‐Kraemer, M.; Meijer, P.; Van, E. M. Journal: International journal of laboratory hematology Issue: Volume 35:Issue 3(2013:Jun.) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preincubation in the Prothrombinase‐induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxaban. Issue 4 (14th November 2012) Authors: Kluft, C.; Meijer, P.; Kret, R.; Burggraaf, J. Journal: International journal of laboratory hematology Issue: Volume 35:Issue 4(2013:Aug.) Page Start: 379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. (14th May 2015) Authors: Zantek, N. D.; Hsu, P.; Meijer, P.; Smock, K. J.; Plumhoff, E. A.; Refaai, M. A.; Van Cott, E. M. Journal: International journal of laboratory hematology Issue: Volume 37:(2015) Supplement 1 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗